Ignite Creation Date:
2025-12-25 @ 12:22 AM
Ignite Modification Date:
2026-01-11 @ 1:31 AM
Study NCT ID:
NCT03184558
Status:
TERMINATED
Last Update Posted:
2021-11-09
First Post:
2017-05-30
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With TNBC
Sponsor:
BerGenBio ASA
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-07-26
Start Date Type:
ACTUAL
Primary Completion Date:
2018-08-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-08-20
Completion Date Type:
ACTUAL
First Submit Date:
2017-05-30
First Submit QC Date:
None
Study First Post Date:
2017-06-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-10-13
Results First Submit QC Date:
None
Results First Post Date:
2021-11-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-10-13
Last Update Post Date:
2021-11-09
Last Update Post Date Type:
ACTUAL